{
    "nctId": "NCT05428527",
    "briefTitle": "Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue",
    "officialTitle": "Real-world Clinical Benefit Evaluation in Breast Cancer Patients With Pharmaceutical Interventions for Cancer-related Fatigue",
    "overallStatus": "COMPLETED",
    "conditions": "Cancer-related Fatigue",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 261,
    "primaryOutcomeMeasure": "Fatigue Improvement",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* breast cancer patients who approved to use NHI to pay for cancer-related fatigue treatment drug\n\nExclusion Criteria:\n\n* N/A",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}